Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gender and lung cancer.

M Patricia Rivera1, Diane E Stover

  • 1Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of North Carolina at Chapel Hill, 4133 Bioinformatics Building CB #7020, Chapel Hill, NC 27599, USA. mprivera@med.unc.edu

Clinics in Chest Medicine
|April 22, 2004
PubMed
Summary

Lung cancer risks and presentation differ between women and men. Factors like DNA damage, repair, mutations, and hormones contribute to women's increased susceptibility, necessitating tailored screening and treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The American Cancer Society National Lung Cancer Roundtable strategic plan: Challenges in clinical guideline recommendations for biomarker testing in lung cancer.

Cancer·2026
Same author

Nicotine-free generations: a bold policy for public health.

The Lancet. Respiratory medicine·2025
Same author

Burden and Impact of Frailty and Comorbidity in Individuals Screened for Lung Cancer.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2025
Same author

Lung Cancer Progress and Promise: Shaping the Future of Care.

Seminars in respiratory and critical care medicine·2025
Same author

Lung Cancer Screening in Cancer Survivors vs Those Without a History of Cancer.

JAMA network open·2025
Same author

Comparison of Underlying Risk of Developing and Dying From Lung Cancer in Screened Populations.

Chest·2025

Area of Science:

  • Oncology
  • Genetics
  • Epidemiology

Background:

  • Lung cancer incidence and outcomes show significant sex-based disparities.
  • Emerging evidence suggests women may have increased susceptibility to tobacco carcinogens.

Purpose of the Study:

  • To summarize the sex and gender differences in lung cancer development and presentation.
  • To highlight the need for sex-specific considerations in lung cancer guidelines.

Main Methods:

  • Review of accumulating data on lung cancer in women versus men.
  • Analysis of biological, genetic, and hormonal factors influencing susceptibility.
  • Examination of differences in lung cancer presentation and diagnosis.

Main Results:

Related Experiment Videos

  • Women exhibit higher DNA adduct levels, reduced DNA repair capacity, and increased tumor suppressor gene mutations.
  • Hormonal differences may contribute to women's susceptibility.
  • Women present with more adenocarcinoma, are diagnosed younger, and are more likely to be diagnosed with lung cancer if they are non-smokers.

Conclusions:

  • Sex and gender significantly influence lung cancer risk, presentation, and potentially treatment response.
  • Current lung cancer guidelines may not adequately address these sex-specific differences.
  • Future research and clinical practice should incorporate sex and gender considerations for improved lung cancer management.